Omega Healthcare Investors Files 8-K
Ticker: OHI · Form: 8-K · Filed: 2024-03-14T00:00:00.000Z
Sentiment: neutral
Topics: 8-K, filing, disclosure
Related Tickers: OHI
TL;DR
OHI filed an 8-K, standard procedure, check for details.
AI Summary
Omega Healthcare Investors, Inc. filed an 8-K on March 14, 2024, to report other events and financial statements. The filing does not contain specific details about new transactions or financial results in the provided text, but indicates the submission of required documentation.
Why It Matters
This filing serves as an official notification to the SEC and investors about significant corporate events or financial updates for Omega Healthcare Investors, Inc.
Risk Assessment
Risk Level: low — The filing is a routine disclosure and does not appear to contain negative news or significant changes.
Key Players & Entities
- OMEGA HEALTHCARE INVESTORS, INC. (company) — Registrant
- March 14, 2024 (date) — Date of earliest event reported
FAQ
What specific 'Other Events' are being reported in this 8-K filing?
The provided text of the 8-K filing does not specify the details of the 'Other Events' being reported, only that this item is included.
What financial statements and exhibits are included with this filing?
The filing indicates that 'Financial Statements and Exhibits' are included, but the specific content of these documents is not detailed in the provided text.
What is the principal executive office address for Omega Healthcare Investors, Inc.?
The principal executive offices are located at 303 International Circle, Suite 200, Hunt Valley, Maryland 21030.
What is the telephone number for Omega Healthcare Investors, Inc.?
The registrant's telephone number, including area code, is (410) 427-1700.
Under which section of the Securities Exchange Act of 1934 is this report filed?
This report is filed pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934.
From the Filing
0001104659-24-034585.txt : 20240314 0001104659-24-034585.hdr.sgml : 20240314 20240314172130 ACCESSION NUMBER: 0001104659-24-034585 CONFORMED SUBMISSION TYPE: 8-K PUBLIC DOCUMENT COUNT: 18 CONFORMED PERIOD OF REPORT: 20240314 ITEM INFORMATION: Other Events ITEM INFORMATION: Financial Statements and Exhibits FILED AS OF DATE: 20240314 DATE AS OF CHANGE: 20240314 FILER: COMPANY DATA: COMPANY CONFORMED NAME: OMEGA HEALTHCARE INVESTORS INC CENTRAL INDEX KEY: 0000888491 STANDARD INDUSTRIAL CLASSIFICATION: REAL ESTATE INVESTMENT TRUSTS [6798] ORGANIZATION NAME: 05 Real Estate & Construction IRS NUMBER: 383041398 STATE OF INCORPORATION: MD FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 8-K SEC ACT: 1934 Act SEC FILE NUMBER: 001-11316 FILM NUMBER: 24751327 BUSINESS ADDRESS: STREET 1: 303 INTERNATIONAL CIRCLE, STREET 2: SUITE 200 CITY: HUNT VALLEY STATE: MD ZIP: 21030 BUSINESS PHONE: 410-427-1700 MAIL ADDRESS: STREET 1: 303 INTERNATIONAL CIRCLE, STREET 2: SUITE 200 CITY: HUNT VALLEY STATE: MD ZIP: 21030 8-K 1 tm248634d7_8k.htm FORM 8-K false 0000888491 0000888491 2024-03-14 2024-03-14 iso4217:USD xbrli:shares iso4217:USD xbrli:shares     UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549       FORM 8-K       CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934   Date of Report (Date of earliest event reported): March 14, 2024   OMEGA HEALTHCARE INVESTORS, INC. (Exact name of registrant as specified in its charter)   Maryland 1-11316 38-3041398 (State or other jurisdiction of incorporation) (Commission File Number) (IRS Employer Identification No.)   303 International Circle Suite 200 Hunt Valley , Maryland 21030 (Address of principal executive offices / Zip Code)   ( 410 ) 427-1700 (Registrant’s telephone number, including area code)   Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:     ¨ Written communications pursuant to Rule 425 under the Securities Act.     ¨ Soliciting material pursuant to Rule 14a-12 under the Exchange Act.     ¨ Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act.     ¨ Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act.   Securities registered pursuant to Section 12(b) of the Securities Exchange Act of 1934:       Title of each class Trading Symbol(s) Name of each exchange on which registered Common Stock, $.10 par value OHI New York Stock Exchange   Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter).   Emerging growth company  ¨   If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act.  ¨           Item 8.01 Other Events.   On March 14, 2024, Omega Healthcare Investors, Inc. (the “Company”), filed with the U.S. Securities and Exchange Commission (the “SEC”) an automatic shelf registration statement on Form S-3ASR (File No. 333-277916) (the “New Registration Statement”) to replace the automatic shelf registration statement on Form S-3ASR (File No. 333-256084) filed with the SEC on May 13, 2021 (the “Prior Registration Statement”). The Prior Registration Statement was terminated upon the effectiveness of the New Registration Statement on March 14, 2024.   In connection with the filing of the